Division of Infectious Diseases, Department of Internal Medicine, Chi Mei Medical Center-Liouying, Tainan City, Taiwan.
Department of Intensive Care Medicine, Chi-Mei Medical Center, Tainan, Taiwan.
J Formos Med Assoc. 2017 Sep;116(9):660-670. doi: 10.1016/j.jfma.2017.06.002. Epub 2017 Jun 21.
BACKGROUND/PURPOSE: Aspergillus-associated infection might comprise up to 23-29% of severe influenza patients from the community throughout stay in an intensive care unit (ICU). In Taiwan, cases of severe influenza with aspergillosis are increasingly reported. Therefore, we describe the relative risk of mortality among severe influenza patients with aspergillosis and other coinfections compared to severe influenza patients without Aspergillus coinfections.
We retrospectively reviewed 124 adult patients with severe influenza in a tertiary medical center in southern Taiwan from January 2015 through March 2016. The definition of probable aspergillosis required abnormal radiological findings and positive Aspergillus galactomannan (GM) antigen and/or Aspergillus isolation.
Probable aspergillosis (detected throughout the whole course) and other coinfections (only community-acquired) were diagnosed in 21 (17%) and 38 (31%) of all patients respectively. Klebsiella pneumoniae (36.8%), Pseudomonas aeruginosa (31.6%) and Staphylococcus aureus (31.6%) were the most frequent isolates of other coinfections. In-ICU mortality of Aspergillus group (66.7%) was significantly higher than other coinfections (23.7%, p = 0.001) or control group without coinfections (15.4%, p < 0.001), with significant odds ratios after adjusting for important variables. The factor of GM index ≥0.6 had a 19.82 (95% CI, 4.91 to 80.07, p < 0.0001) odds of expiring in an ICU among the Aspergillus group.
Dual Aspergillus and influenza infection is emerging in southern Taiwan. Meanwhile, community-acquired P. aeruginosa should be listed in the common copathogens with severe influenza. The 67% mortality linked to aspergillosis highlights the need for physicians to focus attention on patients with GM ≥ 0.6.
背景/目的:曲霉菌相关感染可能占社区重症流感患者入住重症监护病房(ICU)期间的 23-29%。在台湾,越来越多的严重流感伴曲霉菌病的病例被报道。因此,我们描述了与无曲霉菌合并感染的严重流感患者相比,合并曲霉菌感染和其他合并感染的严重流感患者的死亡率的相对风险。
我们回顾性分析了 2015 年 1 月至 2016 年 3 月在台湾南部一家三级医疗中心的 124 例成年严重流感患者。疑似曲霉菌病的定义需要异常的影像学发现和阳性的曲霉菌半乳甘露聚糖(GM)抗原和/或曲霉菌分离。
在所有患者中,分别有 21 例(17%)和 38 例(31%)被诊断为疑似曲霉菌病(整个病程中均存在)和其他合并感染(仅为社区获得性)。最常见的其他合并感染分离株是肺炎克雷伯菌(36.8%)、铜绿假单胞菌(31.6%)和金黄色葡萄球菌(31.6%)。曲霉菌组的 ICU 死亡率(66.7%)明显高于其他合并感染组(23.7%,p=0.001)或无合并感染组(15.4%,p<0.001),在调整了重要变量后,差异具有统计学意义。GM 指数≥0.6 的因素使曲霉菌组 ICU 死亡率增加了 19.82 倍(95%可信区间,4.91 至 80.07,p<0.0001)。
曲霉菌和流感的双重感染在台湾南部逐渐出现。同时,社区获得性铜绿假单胞菌应被列入与严重流感常见的共病原体。与曲霉菌病相关的 67%的死亡率强调了医生需要关注 GM 值≥0.6 的患者。